Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment
Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment …

In 9–20% of cases, Sjögren's syndrome is associated with various respiratory symptoms.
The most typical manifestations are chronic interstitial lung disease (ILD) and …

Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease, characterized by
lymphocytic infiltration of the secretory glands. This process leads to sicca syndrome, which …

Sjogren's syndrome is characterized by the presence of a plethora of autoantibodies (Table
1). We herein review major recent development in autoantibodies associated with Sjogren …

Interstitial lung disease (ILD) has been reported in 3 to 11% of patients with primary
Sjögren's syndrome (pSS). The aims of this retrospective multicenter study were to: 1) …

Primary Sjogren syndrome (pSS) is a systemic autoimmune disease characterised by
lymphocytic infiltration of exocrine glands and by a number of systemic manifestations …

Extraglandular manifestations (EGMs) in primary Sjogren's syndrome (pSS) represent the
clinical expression of the systemic involvement in this disease. EGMs are characterized by a …

Background Primary Sjögren syndrome (pSS) is a chronic inflammatory autoimmune
disease that is characterized by lymphocytic infiltration of the exocrine glands and …

Small airway disease (SAD) is a pathological condition that affects the bronchioles and non-
cartilaginous airways 2 mm or less in diameter. These airways play a crucial role in …

Background Interstitial lung disease (ILD) is a severe pulmonary complication in
inflammatory rheumatic diseases (IRD) and associated with significantly increased morbidity …